Real world eligibility and prognostic relevance for sacubitril/valsartan in unselected heart failure outpatients: data from an Italian registry (IN-HF outcome)
28 August 2018 (08:30 - 12:30)
Organised by:
Abstract
Slides
About the speaker
Polyclinic - Monza C.D.C Health Centre, Monza (Italy)
7 More presentations in this session
Access the full session
The Event
ESC Congress 2018
28 August 2018
08:30 CET
You may be interested in
Congress Presentation
